Regencell Bioscience Holdings Limited (RGC) focuses on TCM-based treatments for ADHD and Autism, targeting significant ...

Niagen Bioscience, Inc. (NASDAQ: NAGE), the global authority on NAD+ (nicotinamide adenine dinucleotide) with a focus on the science of healthy aging, today announced that its CEO, Rob Fried, will ...

Satellos Bioscience (NASDAQ:MSLE) said interim six-month data from its ongoing TRAILHEAD study showed encouraging safety and ...

On July 6, 2026, Evercore ISI downgraded Twist Bioscience Corporation (NASDAQ:TWST) to In Line from Outperform with a price ...

Niagen Bioscience, Inc. (NASDAQ: NAGE), the global authority on NAD+ science, today announced the formal launch of the first drug candidate of NAD Pharmaceuticals Corp., its wholly owned subsidiary ...

SK bioscience completed on Thursday a periodic World Health Organization Good Manufacturing Practice (WHO GMP) review through ...

PM ETRegister here SAN DIEGO, July 09, 2026 (GLOBE NEWSWIRE) -- (NASDAQ: DARE), a purpose-driven health biotech company ...

Shares of Satellos Bioscience rose after it reported its investigational drug candidate SAT-3247 for adults living with Duchenne muscular dystrophy showed positive results. The stock was up 16% to $9.

Don't buy a "borrowed science" NAD supplement. Discover how Niagen Bioscience’s patented NR safely and efficiently boosts ...

SK bioscience was selected to lead the Gates Foundation-funded ROTOR project, establishing a global collaboration framework.SK bioscience, PATH, Slalom, and SK AX will jointly develop an AI-powered ...

NAD+ levels fall up to 65% as we age. Learn the clinical science behind Niagen Bioscience's NAD precursor and how it fights ...

The ROTOR platform will initially be developed and validated using rotavirus vaccine datasets.